Along KDIGO AKI stages, we observed a statistically significant difference with an increased (TIMP-2) x (IGFBP7) levels in KDIGO AKI stage 3 at POD1 only (p = .003) (Table 4). This evidence concerns the gene TIMP2 and acute kidney injury.